TheProfitWatch

NTHI - NeOnc Technologies Holdings, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.98 -0.33 (-3.01%) --- --- --- --- -0.33 (-3.01%) --- ---

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.3
Diluted EPS:
-0.3
Basic P/E:
-35.5
Diluted P/E:
-35.5
RSI(14) 1m:
90.0
VWAP:
10.73
RVol:
0.3271

Events

Period Kind Movement Occurred At

Related News